- Home
- CLNN vs LSTA Comparison
CLNN vs LSTA Comparison
Compare CLNN & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- LSTA
- Stock Information
- Founded
- CLNN 2012
- LSTA 1980
- Country
- CLNN United States
- LSTA United States
- Employees
- CLNN N/A
- LSTA N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- LSTA Misc Health and Biotechnology Services
- Sector
- CLNN Health Care
- LSTA Health Care
- Exchange
- CLNN Nasdaq
- LSTA Nasdaq
- Market Cap
- CLNN 23.1M
- LSTA 22.3M
- IPO Year
- CLNN N/A
- LSTA N/A
- Fundamental
- Price
- CLNN $5.95
- LSTA $2.11
- Analyst Decision
- CLNN Strong Buy
- LSTA Strong Buy
- Analyst Count
- CLNN 5
- LSTA 2
- Target Price
- CLNN $33.00
- LSTA $23.50
- AVG Volume (30 Days)
- CLNN 101.0K
- LSTA 28.2K
- Earning Date
- CLNN 08-14-2025
- LSTA 08-07-2025
- Dividend Yield
- CLNN N/A
- LSTA N/A
- EPS Growth
- CLNN N/A
- LSTA N/A
- EPS
- CLNN N/A
- LSTA N/A
- Revenue
- CLNN $286,000.00
- LSTA $1,070,000.00
- Revenue This Year
- CLNN N/A
- LSTA N/A
- Revenue Next Year
- CLNN $2,178.18
- LSTA N/A
- P/E Ratio
- CLNN N/A
- LSTA N/A
- Revenue Growth
- CLNN N/A
- LSTA N/A
- 52 Week Low
- CLNN $2.28
- LSTA $1.87
- 52 Week High
- CLNN $6.90
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- CLNN 65.46
- LSTA 34.25
- Support Level
- CLNN $5.12
- LSTA $2.55
- Resistance Level
- CLNN $6.49
- LSTA $2.63
- Average True Range (ATR)
- CLNN 0.63
- LSTA 0.17
- MACD
- CLNN 0.10
- LSTA -0.04
- Stochastic Oscillator
- CLNN 81.76
- LSTA 3.70
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.